Farmaci Genotossici § Farmaci Cancerogeni § Carcinogenic Drugs § Genotoxic Drugs

Abbreviazioni usate nella bibliografia per alcune opere più con­sultate.

 

Allergic

Allergic Reactions to Drugs. Ed. A. L. de Week, H. Bundgaard (Handbook of Experimental Pharmacolo­gy, vol. 63, Springer, Berlin 1983).

Analytical

 

Analytical Profiles of Drug Substances. Volumi: 1 (1972),2 (1973), 3 (1974), 4 (1975),5 (1976),6 (1977),7 (1978), 8 (1979), 9 (1980), 10 (1981), 11 (1982), 12 (1983), 13 (1984), 14 (1985), 15 (1986), 16 (1987), 17 (1988), Ed. K. Florey (Academic Press).

Biological I°

Biological Reactive Intermediates: Formation, Toxici­ty and Inaclivation. Ed. D. 1. Jollow el al. (Plenum Press, New York, London 1977).

Biological II°

Biological Reactive Intermediates II°: Chemical Me­chanisms and Biological Effe<:ts. Ed. R. Snyder e1. al. Pan A (p.I-846) (Advances in Experimental Medici­ne and Biology, vol. 136 A) (Plenum Press, New York, London 1982). Part B (p. 847-1476) (Advances in Experimental Medicine and Biology, vol. 136 B) (plenum Press, New York, London 1982).

Biological III°

Biological Reactive Intermediates III°: Mechanisms of Action in Animal Models and Humans Diseases. Ed. J. J. Kocsis et at. (Advances in Experimental Me­dicine and Biology, vol. 197) (plenum Press, New York, London 1986).

C.A.

Chemical Abstracts (The American Chemical Society, Columbus, Ohio, U.S.A.).

Concepts

Concepts in Biochemical Pharmacology. P. I (1971), P. II (1971). Ed. B. B. Brodie, J. R. Gillette. P. IIIª (1975). Ed. J. R. Gilleue, J. R. Mitchell (Handbuch der experimentellen Pharmakologie, vol. XXVIII, Springer, Berlin).

de Gruchy

G. C. de Gruchy. Drug-Induced Blood Disorders (Blackwell Scientific Pubblicalions, Oxford 1975).

Developments

Developmenls in the Science and Practice of Toxico­logy. Ed. A. W. Hayes et al. (Vol. 11 della serie: Deve­lopments in Toxicology and Environmental Science. Elsevier, 1983).

Dewar

M. J. Dewar, R. C. Dougherty. The PMO Theory of Organic Chemistry (Plenum Press, New York, London 1975).

Drug Metab. Tox.

Drug Metabolism and Drug Toxicity.. Ed. J. R. Mi­tchell, M. G. Horning (Raven Press, New York 1984).

FCMM

Foreing Compounds Melabolism in Mammals. Senior Reporter D. B. Hathway (The Chemical Society, Lon­don). Voll. 2 (1972), 3 (1975),4 (1977),5 (1979).

Fusco

R. Fusco, G. Bianchetti, V. Rosnati. Chimica Organi­ca. Due voll. (L. G. Guadagni, Milano 1969).

Girwood

Blood Disorders due to Drugs and other Agents. Ed. R. H. Girwood (Excerpta Medica, Amsterdam 1973).

Gorrod

Drug Toxicity. Ed. J. W. Gorrod (Taylor and Francis, London 1979).

Hepatic

Drug-Induced Hepatic Injury. Ed. B. H. Ch. Striker, P. Spoelstra (Vol. 10 di: Drug-Induced Disorders. Ed. M. N. G. Dukes. Elsevier 1985).

IARC

International Agency of Research on Cancer Mono­graphs. Vedi : H. Vainio, K. Hemminki, J. Wilbourn. Data on the carcinogeneticy of chemicals in the IARC Monographs. Carcinogenesis 6 (11) 1653-1655 (1985). E’ un riassunto tabellare, con aggiornamenti, dei risul­tati raccolti nei 38 volumi delle IARC Monographs.

Informatore

L'Informatore Farmaceutico. Pubblicazione annuale (Organizzazione Editoriale Me­dico Farmaceutica, Milano).

M. I.

Merck Index, 10ª edizione (Merck and Co. Rahway, N. J., U.S.A. 1983).

Progress D. Metab.

Progress in Drug Metabolism. Ed. J. W. Bridges, L. F. Chasseaud. Voll. 1 (1976),2 (1977),3 (1979),4 (1980),5 (1980), 6 (1981), 7 (1982), (J. Wiley, New York); 8 (1984), 9 (1986), 10 (1987) (Taylor and Fran­cis, London, Philadelphia).

Progress D. Res.

Progress in Drug Research. Voll. da 1 (1959) a 32 (1988). Ed. E. Jucker (Birkhäuser, Basel).

Pryor

Free Radicals in Biology. Ed. W. A. Pryor. Voll. 1 (1976),2 (1976),3 (1977),4 (1980),5 (1982),6 (1984), (Acad. Press, New York).

Reeves

Toxicology: Principles and Practice. Vol. 1° Ed. A. L. Reeves (J. Wiley, New York 1981).

SARC

Second Annual Report on Carcinogens. Environmen­tal Protection Agency (U.S. EPA). National Toxicolo­gy Program (NTP 81-43) Dec. 1981 (GPO: Washin­gton D. C.). Vedi: S. Nesnow et al. Chemical Carcino­gens. A review and analysis of the literature of sele­cted chemicals and the establishment of the Gene-Tox Carcinogen Data Base. A Report of the U.S. Environ­mental Protection Agency (EPA) Gene-Tax Program (GTP). Mutat. Res. 185, 1-195 (1986).

Schiff

Diseases of the Liver. 3a edizione. Ed. L. Schiff. (Lip­pincot Co., Philadelphia, Toronto 1969).

Schmähl

D. Schmähl. Iatrogenic Carcinogenesis (Springer, Berlin 1977).

Searle

Chemical Carcinogens. Ed. Ch. E. Searle (American Chemical Sociely Monograph 173, Washington D. C. 1976).

Searle IIª ed.

Chemical Carcinagens. Ed. Ch. E. Searle. Second E­dition. Vol. 1: cap. 1-11; vol. 2: cap. 12-22 (American Chemical Society Monograph 182, Washington D. C. 1984).

SED

Side Effects of Drug. Voll. 4 (1964), 5 (1966) Ed. L. Meyer; voll. 6 (1968), 7 (1972) Ed. L. Meyer, A. Her­xheimer. Meyer's Side Effects of Drugs. Voll. 8 (1975), 9 (1980), 10 (1984) Ed. M. N. Dukes (Elsevier, Am­sterdam). SED Annual 8 (1984), 9 (1985), 10 (1986), 11 (1987),12 (1988).

Spadoni

M. Spadoni. Pericoli da Farmaci. 8a edizione (Idel­son, Napoli 1975).

USAN 1989

USAN 1989 1961-1988 cumulative lisl. USAN and the USP dictionary of drug names (U. S. Pharmacopeial Convention, Rockville Md 1988).

 

AVVERTENZE

Nel testo, il carattere corsivo neretto è usato solo, e non sem­pre, per i "farmacodinamici" [1.2.1], oggetto principale della ricerca; le altre sostanze sono scrilte in corsivo semplice o in caratteri normali.

Nel testo e nelle tabelle le sostanze sono "identificate" col numero che portano nel Merck Index, ed. X (1983).


Contenuti Scientifici

Menu Principale

Login

Chi è on line

Abbiamo 13 visitatori e nessun utente online